Zentalis Pharmaceuticals Shares Are Trading Higher After Wedbush Maintained a Neutral Rating on the Stock and Raised Its Price Target From $12 to $15
在Wedbush维持对该股的中性评级并将其目标股价从12美元上调至15美元之后,Zentalis制药的股价走高
Zentalis Pharmaceuticals Shares Are Trading Higher After Wedbush Maintained a Neutral Rating on the Stock and Raised Its Price Target From $12 to $15
在Wedbush维持对该股的中性评级并将其目标股价从12美元上调至15美元之后,Zentalis制药的股价走高
使用浏览器的分享功能,分享给你的好友吧